首页> 外文期刊>Urology >Management of nephropleural fistula after supracostal percutaneous nephrolithotomy.
【24h】

Management of nephropleural fistula after supracostal percutaneous nephrolithotomy.

机译:经肋上经皮肾镜取石术后肾胸膜瘘的处理。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Access to complex urinary tract pathology may require supracostal access placing patients at risk for intrathoracic complications. Our objective was to retrospectively review our experience with percutaneous renal surgery with a particular emphasis on identifying the incidence of nephropleural fistula and management of this unusual complication. METHODS: The records of 375 consecutive patients who underwent percutaneous renal surgery between 1993 and 2001 were reviewed. Supracostal access was placed to address the intrarenal pathologic findings most directly in 120 (26.0%) of the 462 tracts, with 87 (18.8%) above the 12th rib, 32 (6.9%) above the 11th rib, and 1 (0.2%) above the 10th rib. RESULTS: Of 375 patients, 4 (1%) developed a nephropleural fistula. Of the 87 with supracostal-12th rib access, 2 (2.3%) developed a nephropleural fistula, and 2 (6.3%) of the 32 with supracostal-11th rib access developed the same complication. The overall incidence of nephropleural fistulas in our patientpopulation per access tract placed was 0.87% (4 of 462 percutaneous tracts), which increased to 3.3% (4 of 120) when considering only supracostal access. All patients were treated conservatively, although 1 patient required thoracoscopy with decortication for persistent pleural effusion. No further sequelae developed in any of the other 3 patients, and all fistulas had resolved at 3 months of follow-up. CONCLUSIONS: As aggressive percutaneous renal surgery with supracostal access to the collecting system becomes more common, the incidence of intrathoracic complications, including nephropleural fistula, may increase. Early recognition and management of a pleural injury is critical to avoid life-threatening situations. Low-morbidity measures are typically successful; however, more aggressive treatment may be required on occasion.
机译:目的:进入复杂的尿路病理可能需要肋上通路,使患者有胸腔内并发症的风险。我们的目的是回顾性地回顾我们在经皮肾外科手术中的经验,尤其侧重于确定肾膜胸膜瘘的发生率和这种异常并发症的处理。方法:回顾性分析了1993年至2001年间375例行经皮肾手术的患者的病历。上肋膜入路最直接地解决了462道中的120道(26.0%)的肾内病理发现,其中第12肋以上的有87(18.8%),第11肋以上的有32(6.9%),而1肋(0.2%)在第十肋骨上方。结果:在375例患者中,有4例(1%)出现了肾胸膜瘘。在第十二肋上肋骨入路的87例中,有2例(2.3%)发生了肾胸膜瘘,在第11肋上肋骨的32例中有2例(6.3%)发生了相同的并发症。在我们每个入路患者中,患者的肾胸膜瘘总发生率为0.87%(462个经皮道中的4个),当仅考虑肋上穿刺入路时,增加到3.3%(120个中有4个)。所有患者均接受了保守治疗,尽管有1例患者需要进行胸腔镜检查,并进行剥脱术以持续性胸腔积液。其他3例患者均未再出现后遗症,并且在随访3个月时所有瘘管均已消退。结论:随着积极的经皮肾外科手术进入肋骨上方进入收集系统变得更加普遍,胸腔内并发症(包括肾胸膜瘘)的发生率可能会增加。早期识别和处理胸膜损伤对于避免危及生命的情况至关重要。低发病率措施通常是成功的;但是,有时可能需要更积极的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号